Tag: Marketing & Interaction with Healthcare Providers

Blog Posts (2)

April 9, 2014

US jury orders Takeda, Eli Lilly to pay $9 billion in damages over Actos

[FirstWordPharma] A US jury ordered Takeda and Eli Lilly to pay a combined $9 billion in punitive damages after finding that the companies concealed the cancer risks associated with the diabetes therapy Actos (pioglitazone). The jury also awarded compensatory damages to the plaintiff of nearly $1.5 million in the first federal lawsuit related to the […]
April 2, 2014

Med-school officials risk conflicts by serving on pharma boards

[FiercePharma] Much has been made recently over the potential conflicts of interest that arise when doctors take speaking fees from pharma companies. But as a new report suggests, some companies are shelling out a whole lot more to keep medical school and hospital leaders on their boards–where conflicts-of-interest could be much further-reaching. As The Wall […]